Could T Cells Lead to New MS Treatments?

Guest: Shivashankar Othy, DVM, PhD

Despite the high prevalence of multiple sclerosis (MS), there’s still a lot we don’t know about this disease. One such area of uncertainty is in regard to how MS causes the immune system to become dysfunctional, but this knowledge is key as it could help us develop new treatment options. And now, we might be one step closer to discovering those treatments thanks to a recent study exploring specific T cells, and joining Dr. Jerome Lisk to discuss that study is Dr. Shiva Othy, a Project Scientist in the Department of Physiology and Biophysics at the University of California Irvine School of Medicine.